Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 1

Interventions

pembrolizumab 244 Nivolumab 140 Cisplatin 135 Cyclophosphamide 134 Paclitaxel 113 Carboplatin 108 Gemcitabine 98 Radiotherapy 83 Dexamethasone 83 Docetaxel 77 atezolizumab 68 Ipilimumab 68 Doxorubicin 62 Fluorouracil 60 Blood Specimen Collection 58 Bevacizumab 58 fludarabine 54 Rituximab 54 Etoposide 53 Oxaliplatin 52 Surveys and Questionnaires 49 Lenalidomide 49 Prednisone 47 Standard of Care 45 Magnetic Resonance Spectroscopy 45 Cetuximab 44 Capecitabine 44 lenvatinib 43 Radiosurgery 43 durvalumab 42

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Antiemetics × 1 year × Clear all

NCT06242691 2026-06-05

MK-1200-002

Merck Sharp & Dohme LLC

Phase 1/2 Completed

13 enrolled 21 charts

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡